Basic Information
| LncRNA/CircRNA Name | RP11-359E19.2 |
| Synonyms | RP11-359E19.2 |
| Region | GRCh38_8:40114651-40127468 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | Microarray, qPCR etc. |
| Sample | bladder cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | Five lncRNAs and four mRNAs were chose for verification of the microarray results in 30 pairs of samples by quantitative real-time PCR. qRT-PCR assay showed that the expression of lncRNA RP11-359E19.2 was upregulated, whereas AL928768.3 and AC002519.6 as well as RP11-79H23.3 and AK021804 were downregulated. |
| Pubmed ID | 27363013 |
| Year | 2016 |
| Title | Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma. |
External Links
| Links for RP11-359E19.2 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |